Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

BMC Cancer
Relinde I Y LieversePhilippe Lambin

Abstract

About 50% of non-small cell lung cancer (NSCLC) patients have metastatic disease at initial diagnosis, which limits their treatment options and, consequently, the 5-year survival rate (15%). Immune checkpoint inhibitors (ICI), either alone or in combination with chemotherapy, have become standard of care (SOC) for most good performance status patients. However, most patients will not obtain long-term benefit and new treatment strategies are therefore needed. We previously demonstrated clinical safety of the tumour-selective immunocytokine L19-IL2, consisting of the anti-ED-B scFv L19 antibody coupled to IL2, combined with stereotactic ablative radiotherapy (SABR). This investigator-initiated, multicentric, randomised controlled open-label phase II clinical trial will test the hypothesis that the combination of SABR and L19-IL2 increases progression free survival (PFS) in patients with limited metastatic NSCLC. One hundred twenty-six patients will be stratified according to their metastatic load (oligo-metastatic: ≤5 or poly-metastatic: 6 to 10) and randomised to the experimental-arm (E-arm) or the control-arm (C-arm). The C-arm will receive SOC, according to the local protocol. E-arm oligo-metastatic patients will receive SABR ...Continue Reading

References

Jul 3, 2003·The Laryngoscope·Manfred T BirchlerSandro J Stoeckli
Jun 14, 2005·Expert Opinion on Therapeutic Targets·Andreas Menrad, Hans D Menssen
Oct 6, 2005·Experimental Lung Research·Zia A KhanSubrata Chakrabarti
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Mar 5, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Bernard M TijinkGuus A M S van Dongen
Apr 8, 2010·Clinical & Experimental Metastasis·Jin-Kyu KangUi-Sup Shin
Jun 1, 2010·International Journal of Radiation Oncology, Biology, Physics·Carlo GrecoYoshiya Yamada
Aug 28, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Manfred JohannsenFilippo de Braud
Oct 1, 2010·Medical Physics·Stanley H BenedictFang-Fang Yin
Oct 27, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas K EigentlerClaus Garbe
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Nov 2, 2014·Breast Cancer Research and Treatment·Ezzeldin M IbrahimGhieth A Kazkaz
Jan 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Catharina M L ZegersPhilippe Lambin
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jul 4, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Nicolle H RekersPhilippe Lambin
Mar 9, 2017·The Lancet Oncology·Lesley SeymourUNKNOWN RECIST working group
May 26, 2017·The British Journal of Radiology·Evert J Van LimbergenPhilippe Lambin
Jun 10, 2017·Nature Communications·Claire Vanpouille-BoxSandra Demaria
Jun 22, 2017·The New England Journal of Medicine·David P CarboneUNKNOWN CheckMate 026 Investigators
Aug 22, 2017·Cancer Immunology, Immunotherapy : CII·Sridharan GururanganDuane Mitchell
Aug 24, 2017·Acta Oncologica·Evelyn E C de JongAnne-Marie C Dingemans
Aug 25, 2017·Acta Oncologica·Antoine SchernbergEric Deutsch
Sep 20, 2017·Journal of the National Cancer Institute·Ahmed SalemCorinne Faivre-Finn
Sep 21, 2017·Expert Opinion on Drug Safety·Stephen Marabondo, Howard L Kaufman
Oct 5, 2017·Frontiers in Oncology·Derek P BergsmaMichael T Milano
Nov 8, 2017·Nature Communications·Viktor A AdalsteinssonMatthew Meyerson
Dec 7, 2017·The Lancet Oncology·Nicholas L SynRoss A Soo
Dec 15, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Piet OstGert De Meerleer
Mar 14, 2018·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Penny FangSteven H Lin
Aug 7, 2018·International Journal of Particle Therapy·Penny FangSteven H Lin
Aug 10, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kevin JaoFrances A Shepherd
Aug 15, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Siddhartha DevarakondaStefan Michiels
Oct 4, 2018·The New England Journal of Medicine·Scott J AntoniaUNKNOWN PACIFIC Investigators
Feb 20, 2019·Journal for Immunotherapy of Cancer·Elizabeth I BuchbinderDavid F McDermott
Mar 20, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Oscar ArrietaJaime De la Garza

❮ Previous
Next ❯

Citations

Sep 12, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Soehartati A GondhowiardjoAngela Giselvania
Nov 8, 2020·Annual Review of Medicine·Willem W OverwijkJonathan Zalevsky
Dec 8, 2020·International Journal of Radiation Oncology, Biology, Physics·Evert Jan Van LimbergenPhilippe Lambin
Mar 3, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Florian Eichhorn, Hauke Winter
Mar 11, 2021·Advanced Healthcare Materials·Biaggio UricoliErik C Dreaden
Mar 25, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Chukwuka EzeMarcus Unterrainer
Apr 4, 2021·Antibodies·Erin RunbeckSophie Papa
May 4, 2021·The Journal of Clinical Investigation·Timothy P Lippert, Roger A Greenberg
May 4, 2021·Frontiers in Immunology·Renske J E van den BijgaartGosse J Adema
Nov 26, 2021·Journal of Medicinal Chemistry·Adrián Gironda-MartínezDario Neri

❮ Previous
Next ❯

Methods Mentioned

BETA
irradiating
pregnancy test
biopsies

Clinical Trials Mentioned

NCT02477826
NCT02453282
NCT02542293
NCT02492568
NCT02086721
NCT03705403

Software Mentioned

iRECIST
ALEA
RECIST
ImmunoSABR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Thomas EigentlerClaus Garbe
International Journal of Radiation Oncology, Biology, Physics
Evert J Van LimbergenPhilippe Lambin
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Manfred JohannsenFilippo de Braud
© 2022 Meta ULC. All rights reserved